Anything that helps Americans lose weight, reduces treatment barriers and makes care more affordable should be welcomed. But ...

Wegovy pills are now available in the U.S., offering a prescription-based, convenient alternative for weight management ...

By Sriparna Roy Jan 23 (Reuters) - Novo Nordisk's Wegovy pill was prescribed more than 18,000 times in the U.S. in the first ...

In December, Novo Nordisk announced that the Food and Drug Administration had approved its once-daily Wegovy pill, the first oral GLP-1 medicine for obesity in the United States. It remains the only ...

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

The Wegovy pill is the first and only oral GLP-1 for weight loss in adults. The first and only oral GLP-1 for weight loss in adults is now available to consumers. Drugmaker Novo Nordisk announced ...

Novo Nordisk has launched the first once-daily GLP-1 weight-loss pill, an oral version of Wegovy approved by the FDA last month. Clinical trials showed the Wegovy pill delivered average weight loss of ...

Popular weight-loss drugs are meant to be lifelong medications treating a disease, not lifestyle fixes.

Danish pharmaceutical giant Novo Nordisk (NVO) has seen a strong rebound at the start of 2026, following two consecutive ...

From nausea and exhaustion to emotional shifts and social awkwardness, people on GLP-1 medications are sharing the side effects they didn't expect — and rarely see talked about.

Some tout a daily semaglutide pill as a game-changer for weight-loss treatment. The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo ...